Nutrigenomics Market Accelerates as Personalized Nutrition and Genetic Testing Transform Preventive Healthcare Worldwide

PUNE, India, July 1, 2026 – The Nutrigenomics Market is witnessing rapid expansion as healthcare systems, wellness providers, and consumers increasingly shift toward personalized nutrition based on genetic profiling. According to Stellar Market Research, the global market was valued at USD 779.14 million in 2025 and is projected to reach USD 3,174.04 million by 2032, registering a robust CAGR of 16.89% during the forecast period. This growth is being driven by rising demand for preventive healthcare solutions and expanding adoption of genetic testing across clinical and direct-to-consumer wellness ecosystems.

Personalized Nutrition and Genomic Science Reshape Healthcare Models

The Nutrigenomics Market is transitioning from experimental research into a commercially scalable healthcare segment, where diet recommendations are increasingly guided by individual genetic profiles. Healthcare providers are integrating nutrigenomic insights into chronic disease management strategies, particularly for obesity, diabetes, cardiovascular conditions, and metabolic disorders.

Advancements in sequencing technologies, bioinformatics, and AI-powered health analytics are enabling more accurate interpretation of genetic data, allowing companies to deliver highly personalized dietary plans. The expansion of direct-to-consumer genetic testing platforms is also democratizing access, making personalized nutrition solutions more widely available beyond traditional clinical environments.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://www.stellarmr.com/report/req_sample/nutrigenomics-market/2392

Key Findings from the Report

The global Nutrigenomics Market was valued at USD 779.14 million in 2025 and is projected to reach USD 3,174.04 million by 2032, growing at a CAGR of 16.89%.
Services segment dominates due to strong demand for personalized dietary consulting and genetic testing services.
Obesity and chronic disease applications remain key demand drivers for nutrigenomics adoption globally.
North America holds the largest market share, supported by advanced healthcare infrastructure and high awareness of genetic testing.
Asia-Pacific is emerging as the fastest-growing region due to rising healthcare spending and preventive wellness trends.
Increasing integration of AI and genomic sequencing is improving accuracy and scalability of personalized nutrition platforms.

Market Drivers and Restraints

The Nutrigenomics Market is primarily driven by rising prevalence of lifestyle-related diseases, increasing consumer interest in personalized healthcare, and growing awareness of the link between nutrition and genetic expression. The expansion of preventive healthcare models is encouraging early adoption of genetic-based diet planning, particularly among urban populations.

However, the market faces restraints such as high costs of genetic testing, limited reimbursement frameworks, data privacy concerns, and lack of standardized clinical guidelines. Ethical considerations around genetic data usage and uneven accessibility in developing regions also remain key challenges.

Technology, Regulation, and Sustainability Trends

Technological advancements such as next-generation sequencing (NGS), AI-driven bioinformatics platforms, and cloud-based genomic data analytics are significantly enhancing the efficiency of nutrigenomics solutions. Digital health ecosystems are increasingly integrating mobile applications and wearable devices to provide continuous personalized nutrition guidance.

From a regulatory perspective, governments and healthcare authorities are gradually establishing frameworks for genetic data protection, consumer consent, and clinical validation of nutrigenomic services. Sustainability trends are also emerging through preventive healthcare adoption, reducing long-term healthcare burden by enabling early lifestyle interventions.

Regional Insights

North America continues to dominate the Nutrigenomics Market due to high prevalence of chronic diseases, advanced healthcare infrastructure, and strong presence of leading genetic testing companies. Europe follows closely with increasing adoption of preventive healthcare and personalized medicine initiatives.

Asia-Pacific is expected to register the fastest growth during the forecast period, driven by rising health awareness, expanding middle-class populations, and increasing investment in genomics research. Emerging markets in Latin America and the Middle East are also witnessing gradual adoption supported by growing wellness and diagnostics industries.

Recent Industry Developments

23andMe (2025): Expanded its genetic testing and health insights platform to strengthen personalized wellness and nutrition-related offerings.
Nutrigenomix (2025): Enhanced clinician-focused nutrigenomic testing solutions for personalized dietary planning in healthcare settings.
Mapmygenome (2025): Expanded genomic testing services in India focusing on preventive healthcare and lifestyle disease management.
Illumina (2025): Advanced sequencing platforms improving accuracy and scalability of nutrigenomic research applications.
DNAlysis Biotechnology (2025): Strengthened genetic testing services across preventive healthcare and nutrition consulting markets.

Analyst Commentary

“Nutrigenomics is moving from a niche scientific concept to a mainstream component of preventive healthcare. The convergence of genomics, AI analytics, and personalized nutrition is expected to redefine how dietary interventions are designed and delivered globally,” said a Senior Research Analyst at Stellar Market Research.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://www.stellarmr.com/report/req_sample/nutrigenomics-market/2392

Future Outlook

The Nutrigenomics Market is expected to witness sustained high growth through 2032 as healthcare systems increasingly prioritize preventive and personalized care models. Continuous advancements in sequencing technologies, AI-driven diagnostics, and consumer health platforms will expand adoption across both clinical and wellness sectors.

Over the forecast period, the industry is likely to evolve toward fully integrated digital health ecosystems where genetic data, lifestyle monitoring, and nutritional guidance converge into real-time personalized healthcare solutions.

About Stellar Market Research

Stellar Market Research is a global market intelligence and consulting firm delivering strategic insights across healthcare, biotechnology, pharmaceuticals, consumer health, chemicals, IT, and industrial sectors. The company provides data-driven research reports, forecasting models, and customized consulting solutions that help organizations understand emerging market dynamics, evaluate competitive landscapes, and identify long-term growth opportunities. With a strong focus on accuracy and actionable insights, Stellar Market Research enables enterprises, investors, and policymakers to make informed strategic decisions in rapidly evolving global markets.